{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hyperthyroidism/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"535b7a8d-3411-51df-831d-85332e2925e0","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 31b2edaf-9fac-4630-9049-4e25476dfe0b --><h2>When should I suspect a diagnosis of hyperthyroidism?</h2><!-- end field 31b2edaf-9fac-4630-9049-4e25476dfe0b -->","summary":"","htmlStringContent":"<!-- begin item b577154a-54f4-4dd7-957f-84a47fe9e5df --><!-- begin field 29c8cf90-10aa-45ec-8504-3c48b0be9eb2 --><p><strong>The symptoms and signs of hyperthyroidism may be mild and non-specific, especially in the elderly. The clinical presentation can also vary depending on the person's co-morbidities and the underlying cause of hyperthyroidism.</strong></p><ul><li><strong>Suspect a diagnosis of hyperthyroidism if there are one or more symptoms of:</strong><ul><li>Rapid-onset malaise, fever, and thyroid pain (may suggest <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">subacute thyroiditis</a>).</li><li>Compression symptoms of breathlessness, hoarse voice, dysphagia, neck pressure (may be caused by a <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">toxic multinodular goitre</a>).</li><li>Agitation, emotional lability, insomnia, irritability, anxiety, palpitations.</li><li>Exercise intolerance, fatigue, muscle weakness.</li><li>Heat intolerance, increased sweating.</li><li>Increased appetite with unintentional weight loss, diarrhoea.</li><li>Subfertility, oligomenorrhoea, amenorrhoea.</li><li>Polyuria, thirst, generalized itch.</li><li>Reduced libido, gynaecomastia in men.</li><li>Deterioration in blood glucose control and hyperglycaemia in people with diabetes mellitus. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> for more information.</li><li>Deterioration of co-morbid heart disease, for example in the elderly. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/angina/\">Angina</a> for more information.</li></ul></li><li><strong>Suspect a diagnosis of hyperthyroidism if there are one or more signs of:</strong><ul><li>Agitation, fine tremor, warm moist skin, palmar erythema.</li><li>Sinus tachycardia, atrial fibrillation, heart failure, peripheral oedema.</li><li>Thyroid enlargement (a goitre).<ul><li>In <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">Graves&#39; disease</a>, the thyroid gland is usually diffusely symmetrically enlarged without nodules, and there may be a bruit.</li><li>A <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">toxic multinodular goitre</a> typically presents with non-tender thyroid nodules.</li><li>A <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">toxic adenoma</a> typically presents with a unilateral, non-tender thyroid mass.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">Subacute thyroiditis</a> typically presents with a tender, firm, irregular, diffusely enlarged thyroid gland which may be asymmetrical.</li><li>In <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">amiodarone-induced</a> thyroiditis, a small goitre is usually present.</li></ul></li><li>Pruritus, urticaria, vitiligo, diffuse alopecia.</li><li>Muscle wasting, proximal myopathy, hyper-reflexia.</li><li>Splenomegaly, lymphadenopathy.</li><li>Gynaecomastia in men.</li><li>Extrathyroid manifestations of <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">Graves&#39; disease</a> (rare):<ul><li>Thyroid acropachy (clubbing and swelling of the distal fingers and toes).</li><li>Thyroid dermopathy (slightly pigmented thickened skin and swelling of both legs, usually in the pretibial area).</li></ul></li></ul></li><li><strong>Suspect a diagnosis of Graves' orbitopathy if there are clinical features of:</strong><ul><li>Eye irritation, photophobia, or excessive watering of the eyes.</li><li>Redness of the eyes or eyelids and/or lid swelling.</li><li>Change in the appearance of the eye or eyelids:<ul><li>Eyelid retraction (sclera is visible above the superior corneal limbus).</li><li>Lid lag (delay in moving the eyelid as the eye moves downward).</li><li><div>Proptosis (exophthalmos, eyeball protrusion, an inability to fully close the eyes as the upper and lower lids do not fully appose).</div></li></ul></li><li>Persistent double vision in any direction of gaze (typically when looking upwards and outwards).</li><li>Unexplained deterioration in visual acuity; change in the intensity or quality of colour vision in one or both eyes; orbital aching or restricted eye movements — suggests <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/complications/\">dysthyroid optic neuropathy</a>.</li><li>History of globe subluxation — one or both eyes suddenly 'popping out'; typically lasts more than a few seconds, is painful, and the lids could not be closed.</li><li>Note: be aware that Graves' orbitopathy is often asymmetrical, and is unilateral in 15% of people. It may occur in the context of hyperthyroidism, hypothyroidism, or euthyroidism.</li></ul></li><li><strong>Be aware that clinical symptoms and signs are typically absent, mild, or non-specific in <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/definition/\">subclinical hyperthyroidism</a>.</strong><ul><li>If clinical features are present, they are more likely in younger people.</li></ul></li><li><strong>Suspect the thyroxtoxic phase of <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/background-information/causes/\">postpartum thyroiditis</a> (PPT):</strong><ul><li>Typically between 1–6 months postpartum, which usually lasts only 1–2 months.</li><li>Note: be aware that other conditions such as Graves' disease can also present postpartum. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/management/pre-conception-pregnancy-postpartum/#managing-women-postpartum\">Managing women postpartum</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hyperthyroidism/management/pre-conception-pregnancy-postpartum/\">Scenario: Pre-conception, pregnancy, and postpartum</a> for more information.</li></ul></li></ul><!-- end field 29c8cf90-10aa-45ec-8504-3c48b0be9eb2 --><!-- end item b577154a-54f4-4dd7-957f-84a47fe9e5df -->","topic":{"id":"c3c8bd52-950a-5ac1-a8f6-31ee314de753","topicId":"4369594d-9952-48d2-89e3-17e591c8762d","topicName":"Hyperthyroidism","slug":"hyperthyroidism","lastRevised":"Last revised in January 2021","chapters":[{"id":"59f9bdf8-6311-583d-9fe9-52c678d352db","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"146e5bec-d1eb-5ba0-9e81-f3816c76c97a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"129b45b2-8296-54fd-9b82-246f53a0c38a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"94bb9adc-590a-5092-a39d-eafdcb359b5b","slug":"changes","fullItemName":"Changes"},{"id":"0587f71f-c66c-57d3-82dc-d217875883ba","slug":"update","fullItemName":"Update"}]},{"id":"1056d2a8-5a53-5386-8dab-1f19fc4a963f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d5707303-4d8e-53dd-9591-510f1f75ea88","slug":"goals","fullItemName":"Goals"},{"id":"c725a50c-0e88-5dca-a743-83b0aec2cf6e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"423f188d-b3d1-599b-b36e-d8986253ac12","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a7f71a23-ba29-5115-a37a-e10730ecfebe","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3769fad6-d54a-5b84-9378-d5fed321c43f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f546d633-22ad-5b3a-addf-c14ed5a316e4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a47d1c6f-bb45-556c-9f6f-1be5eb0fee97","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"87205244-f824-5403-8c75-27a9396c3d3c","slug":"definition","fullItemName":"Definition"},{"id":"297effea-8b73-56d9-b953-894efa713b64","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6c2d617f-c4bf-53cd-ad15-3c4e50b4f917","slug":"causes","fullItemName":"Causes"},{"id":"a8477f19-2c3c-55eb-9cf0-52683adbf104","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5d8a6eb0-ae1c-5dc0-976b-c6dc76c822d0","slug":"complications","fullItemName":"Complications"},{"id":"606c2ced-041a-59db-84ad-9bdbc9d30b29","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"25bebca1-01a3-571a-bc2f-de52655661fd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"535b7a8d-3411-51df-831d-85332e2925e0","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"3e2f3be8-a4e7-55cc-a90e-fc9bc179ce65","slug":"assessment","fullItemName":"Assessment"}]},{"id":"c4bec08d-e5b3-509c-bea9-a31e8270f443","fullItemName":"Management","slug":"management","subChapters":[{"id":"4b553103-7c9a-5df2-a66d-ca71eb230d75","slug":"management","fullItemName":"Scenario: Management"},{"id":"f01fb4b1-5479-506a-aab6-3d89022ca8d1","slug":"pre-conception-pregnancy-postpartum","fullItemName":"Scenario: Pre-conception, pregnancy, and postpartum"}]},{"id":"410c1a25-4e25-5a82-9e68-74da126c2a52","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8a4baacf-8743-54dd-b0d2-6f9c63faed0f","slug":"propylthiouracil","fullItemName":"Propylthiouracil"},{"id":"5fecf90d-1aa4-5bb3-9e03-3603d3bff170","slug":"carbimazole","fullItemName":"Carbimazole"},{"id":"9f0433e8-fb86-5755-b708-070c08e61a4e","slug":"beta-blockers","fullItemName":"Beta-blockers"}]},{"id":"d5890c99-4277-5691-82b8-db4d899a0577","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"02257fcd-f37e-5344-be29-947639722e86","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ad43c9e6-b7b5-5112-a0c3-cceb0846f218","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"19745d5f-1ede-5a4c-bc7f-14ffd9dcb077","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"28c4e1a4-4c14-58af-a7eb-7064465157f4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"afef01bd-ae56-54fa-96f9-395242020ab0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1fc2600e-afe1-582b-b40e-ba61a21de9f7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b29c805a-fe2a-529d-a4e8-e0a837f7663c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"25bebca1-01a3-571a-bc2f-de52655661fd","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"47aa9979-9000-563f-904c-5691ee3fbe30","slug":"basis-for-recommendation-bd2","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 8d561742-c214-454b-a15b-0e390b958786 --><h3>Basis for recommendation</h3><!-- end field 8d561742-c214-454b-a15b-0e390b958786 -->","summary":null,"htmlStringContent":"<!-- begin item bd22a0c1-1f7a-4eb8-b5d4-e25cb830ed36 --><!-- begin field c56fc619-7fe1-40fc-beee-ce95b3878f68 --><p>The recommendations on when to suspect hyperthyroidism are based on the National Institute of Health and Care Excellence (NICE) clinical guideline <em>Thyroid disease: assessment and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">NICE, 2019</a>], the joint UK publication <em>UK guidelines for the use of thyroid function tests</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">BTA et al, 2006</a>], the European Thyroid Association (ETA) publications <em>G</em><em>uidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Biondi et al, 2015</a>] and <em>Guideline for the management of Graves' hyperthyroidism</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Kahaly, 2018</a>]; the joint European Thyroid Association (ETA)/European Group on Graves' orbitopathy (EUGOGO) publication <em>Guidelines on the management of Graves' orbitopathy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bartalena, 2016</a>], the American Thyroid Association (ATA) publications <em>Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Ross, 2016</a>] and <em>Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Alexander, 2017</a>]; the Endocrine Society clinical practice guideline <em>Management of thyroid dysfunction during pregnancy and postpartum</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Groot et al, 2012</a>], the Royal College of Physicians (RCP) publication <em>Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Perros et al, 2015</a>], and expert opinion in review articles on hyperthyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Franklyn and Boelaert, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Vaidya and Pearse, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Leo, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Kravets, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bathgate, 2018</a>], on subclinical hyperthyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Biondi, 2018</a>], on investigating thyroid disorders [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Weetman, 2013</a>], and a chapter in a medical textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Weetman, 2010</a>].</p><h4>Clinical features of hyperthyroidism</h4><ul><li>The information that clinical features may be mild and non-specific, especially in the elderly is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">NICE, 2019</a>], expert opinion in the ETA guideline on Graves' disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Kahaly, 2018</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Leo, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bathgate, 2018</a>].</li><li>The information that clinical presentation can also vary depending on the person's age, co-morbidities, and underlying cause is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">NICE, 2019</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Leo, 2016</a>].<ul><li>The NICE guideline notes that having a single symptom of hyperthyroidism is usually not predictive of thyroid dysfunction, and the decision to arrange investigations should be based on an overall clinical suspicion, taking into account the nature and severity of symptoms, clinical signs, and any co-existing conditions.</li></ul></li><li>The information on the possible symptoms and signs of hyperthyroidism is based on the ATA guideline on hyperthyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Ross, 2016</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Leo, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Kravets, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bathgate, 2018</a>].<ul><li>The ATA guideline notes there is only moderate correlation between the degree of biochemical hyperthyroidism and clinical signs and symptoms.</li></ul></li></ul><h4>Clinical features of Graves' orbitopathy</h4><ul><li>The information on when to suspect Graves' orbitopathy are based on the joint ETA/EUGOGO guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bartalena, 2016</a>], the RCP publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Perros et al, 2015</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Vaidya and Pearse, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Leo, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bathgate, 2018</a>].</li><li>The information that Graves' orbitopathy may occur in the context of hyperthyroidism, hypothyroidism, or euthyroidism is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Bathgate, 2018</a>].</li></ul><h4>Clinical features of subclinical hyperthyroidism</h4><ul><li><p>The information that clinical features of subclinical hyperthyroidism are typically absent, mild, or non-specific and more common in younger people is based on the joint UK publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">BTA et al, 2006</a>], the ETA publication on subclinical hyperthyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Biondi et al, 2015</a>], the ATA guideline on hyperthyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Ross, 2016</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Biondi, 2018</a>].</p></li></ul><h4>When to suspect postpartum thyroiditis (PPT)</h4><ul><li>The information on the typical timing and duration of PPT is based on the Endocrine Society clinical practice guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">De Groot et al, 2012</a>] and the ATA guidelines pregnancy and postpartum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Alexander, 2017</a>].<ul><li>The ATA guidelines note the thyrotoxic phase of PPT typically occurs between 2 and 6 months postpartum, but may occur one year following delivery. In addition, other conditions such as Graves' disease can also present postpartum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperthyroidism/references/\">Alexander, 2017</a>].</li></ul></li></ul><!-- end field c56fc619-7fe1-40fc-beee-ce95b3878f68 --><!-- end item bd22a0c1-1f7a-4eb8-b5d4-e25cb830ed36 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}